Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Mitre Ventures is a venture partner established to support early-stage life science startups in the United States. Founded with the mission to advance innovation from pre-seed to seed investments, the firm emphasizes a minimum expectation of demonstrated proof of concept (POC) from its portfolio companies. This focus allows Mitre Ventures to identify and back promising technologies that can lead to significant advancements in healthcare.
The firm operates primarily within the therapeutics sector, targeting areas such as oncology, central nervous system (CNS) disorders, and infectious diseases. Mitre Ventures is headquartered in the United States and is committed to fostering connections between visionary founders and mission-aligned investors. The organization has built a reputation for its strategic approach to early-stage funding, ensuring that it supports startups with the potential to make a meaningful impact in the life sciences.
Mitre Ventures specializes in investments within the therapeutics sector, focusing on areas such as oncology, CNS disorders, and infectious diseases. The firm primarily engages in early-stage, dilutive funding, specifically targeting pre-seed and seed rounds. This investment strategy allows Mitre Ventures to support startups that are in the early phases of development, where capital is crucial for advancing their technologies.
The organization adopts an agnostic approach to disease indications and modalities, welcoming technologies that can generate therapeutics across multiple disease areas and mechanisms. This includes interest in CAR-T, CGT, mRNA, ASO, and small molecules. Mitre Ventures seeks to partner with founders who have a clear vision and a demonstrated proof of concept, ensuring that their investments are aligned with innovative solutions in the life sciences.
Mitre Ventures has not publicly disclosed specific portfolio companies. However, the firm is known for its focus on early-stage life science startups, particularly in the therapeutics sector. The organization emphasizes investments in companies that demonstrate a minimum expectation of proof of concept, which is critical for attracting further funding and advancing their technologies.
While specific names are not available, the firm’s investment strategy includes a diverse range of therapeutic areas, including oncology and CNS disorders. This broad focus allows Mitre Ventures to engage with a variety of innovative startups that are working on groundbreaking solutions in healthcare.
F. Matthew Bakthasekaran, MBA - Founder & General Partner. He has extensive experience in the life sciences sector and leads the investment strategy at Mitre Ventures.
Sal Filardi - Advisory Board Member. He brings a wealth of knowledge in healthcare investments and strategic guidance.
Craig Pierson - Advisory Board Chair. He has a strong background in venture capital and supports the firm’s strategic initiatives.
Tim Foley - Advisory Board Member. He offers insights into market trends and investment opportunities in the life sciences.
Vivian Rodolf - Advisory Board Member. She contributes expertise in biotechnology and helps shape the firm’s investment focus.
Founders can pitch Mitre Ventures through the application form available on their website. It is important to include a clear overview of the technology, the problem it addresses, and the stage of development. The firm values concise and informative decks that highlight the potential impact of the startup's innovations.
As of October 2023, Mitre Ventures continues to actively seek early-stage life science startups for investment. The firm remains focused on the therapeutics sector, emphasizing its commitment to supporting innovative solutions in healthcare.
Recent announcements include the launch of new initiatives aimed at connecting founders with mission-aligned investors, further solidifying Mitre Ventures' role in the life sciences investment community.
What are Mitre Ventures' investment criteria?
Mitre Ventures focuses on early-stage life science startups, particularly in the therapeutics sector. The firm requires a minimum expectation of demonstrated proof of concept (POC) before considering an investment.
How can founders apply for funding?
Founders interested in funding can submit their applications through the designated form available on the Mitre Ventures website.
What makes Mitre Ventures different from other investors?
Mitre Ventures emphasizes a strong alignment between founders and mission-aligned investors, focusing specifically on the therapeutics sector and supporting companies with proven concepts.
What is the geographic focus of Mitre Ventures?
The firm primarily invests in early-stage life science startups located in the United States.
What stages does Mitre Ventures invest in?
Mitre Ventures specializes in pre-seed and seed stage investments, providing crucial funding to startups at the earliest phases of development.
What types of technologies does Mitre Ventures invest in?
The firm welcomes a variety of technologies that can generate therapeutics across multiple disease areas and mechanisms, including CAR-T, CGT, mRNA, ASO, and small molecules.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.